NEULAND LABORATORIES
Back to Income Statement
|
NEULAND LABORATORIES Last 5 Year Earnings Per Share (EPS) History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Adjusted EPS | ₹283.71 | ₹202.74 | ₹233.89 | ₹127.45 | ₹49.74 |
What is the latest Earnings Per Share (EPS) of NEULAND LABORATORIES ?
| Year | Earnings Per Share (EPS) |
|---|---|
| Mar2026 | ₹283.71 |
| Mar2025 | ₹202.74 |
| Mar2024 | ₹233.89 |
| Mar2023 | ₹127.45 |
| Mar2022 | ₹49.74 |
How is Earnings Per Share (EPS) of NEULAND LABORATORIES Trending?
| Years | Earnings Per Share (EPS) | % Change | |
|---|---|---|---|
| Mar2026 | ₹283.71 | 39.94 | |
| Mar2025 | ₹202.74 | -13.32 | |
| Mar2024 | ₹233.89 | 83.52 | |
| Mar2023 | ₹127.45 | 156.23 | |
| Mar2022 | ₹49.74 | - | |
Compare Earnings Per Share (EPS) of peers of NEULAND LABORATORIES
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| NEULAND LABORATORIES | ₹23,770.6 Cr | -2% | 2.8% | 27.1% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹465,711.0 Cr | -0.8% | 3.5% | 14.7% | Stock Analytics | |
| DIVIS LABORATORIES | ₹192,376.0 Cr | -1% | 7.3% | 7.6% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹188,655.0 Cr | -0.9% | 10.1% | 44.6% | Stock Analytics | |
| CIPLA | ₹113,979.0 Cr | -2.1% | -1.8% | -6% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹96,204.7 Cr | -5.8% | -13.2% | -7.7% | Stock Analytics | |
NEULAND LABORATORIES Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| NEULAND LABORATORIES | -2% |
2.8% |
27.1% |
| SENSEX | -2.7% |
-0.2% |
-8% |
You may also like the below Video Courses